The shortage of donor organs highlights the need for innovative techniques to improve organ recovery and rehabilitation.

Award supports the development of a cell-based assay platform to help scientists discover and test drug candidates for liver fibrosis

  Award supports development of a pre-clinical cell-based assay platform to help scientists discover and test drug candidates for metastatic breast cancer

An integral part of mimicking the microenvironment of specific cell types in a tissue culture dish is the use of extracellular matrices (ECM). 

Xylyx Bio, a regenerative medicine company developing innovative solutions for tissue and organ repair, today announced entry into an exclusive license agreement with Vanderbilt University for the rights to a xenogeneic cross-circulation platform that restores damaged donor...

Pulmonary air leak is the most common complication of lung surgery, contributing to post-operative morbidity in up to 60% of patients; yet, there is no reliable treatment. 

That is a missed opportunity to save thousands of lives

The scarcity of suitable donor livers highlights a continuing need for innovation to recover organs with reversible injuries in liver transplantation.

Following a clinical trial, Xylyx Bio’s Matrikyne ingredient was deemed efficacious in combatting anti-aging effects and improving skin appearance.